Suven Life Sciences Limited (BOM:530239)
India · Delayed Price · Currency is INR 354.80
-6.75 (-1.87%)
At close: Sep 11, 2026
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 93.57 billion as of September 11, 2026. Its market cap has increased by 88.56% in one year.
Market Cap
93.57B
Enterprise Value
88.55B
Revenue
88.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
354.80
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 93.57B, an increase of 5,706.28%. That is a compound annual growth rate of 18.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 93.57B | 146.53% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.30B |
| Shilpa Medicare | 188.04B |
| Symbiotec Pharmalab | 72.85B |
| IOL Chemicals and Pharmaceuticals | 61.57B |
| Gujarat Themis Biosyn | 56.13B |
| NGL Fine-Chem | 17.09B |
| Bajaj HealthCare | 11.21B |
| Shree Ganesh Remedies | 8.55B |